Document ID: chunk:federal_register_of_legislation:F2025C00214:clause:1_61647
Version: federal_register_of_legislation:F2025C00214
Segment Type: clause
Provision Reference: sch 1 cl 61647
Character Range: 321989–322958

61647                                Whole body 68Ga‑DOTA‑peptide PET study, if:                                                                                                                                                                                                                                                                                                                                                   953.00
                                     (a) a gastro‑entero‑pancreatic neuroendocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or
                                     (b) both:
                                     (i) a surgically amenable gastro‑entero‑pancreatic neuroendocrine tumour has been identified on the basis of conventional techniques; and
                                     (ii) the study is for excluding additional disease sites (R)
Subgroup 3—Adjunctive services